STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials
Reported by STAT News · all stories from statnews.com
Editorial digest
Insitro's Daphne Koller shares insights on how artificial intelligence can make clinical trials faster. This involves leveraging advanced computational methods for drug development.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom11/10/2026
STAT+: Oura to acquire Counsel Health for $625 million, placing a big bet on AI care
Oura plans to purchase Counsel Health in a $625 million deal focused on artificial intelligence healthcare services.
- Trusted health newsroom11/16/2026
STAT+: Venture capitalist John Doerr says AI company, named for his late brother, could help fix primary care
Investor John Doerr believes an artificial intelligence venture honoring his deceased brother can revitalize primary healthcare.
- Trusted health newsroom10/8/2026
STAT+: Why this startup is taking its AI to predict breast cancer risk directly to patients
A startup is offering AI-driven breast cancer risk assessment directly to individuals.
- Trusted health newsroom10/14/2026
How consumer tech company Whoop is building for Medicare patients
A consumer technology firm is developing products for older adults on Medicare.
- Trusted health newsroom9/3/2026
STAT+: OpenEvidence launches new family of AI models
OpenEvidence introduces a new suite of AI models.
- Trusted health newsroom8/26/2026
STAT+: When it comes to women’s health, money talks
Funding is increasing for innovations in women's health.
